Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 490,728 | 233,175 | 145,238 | 109,460 | 131,836 |
| Cost of Goods | 10,339 | 7,744 | 11,450 | 4,420 | 3,818 |
| Gross Profit | 480,389 | 225,431 | 133,788 | 105,040 | 128,018 |
| Operating Expenses | 543,552 | 550,002 | 522,376 | 425,273 | 328,261 |
| Operating Income | -62,824 | -323,827 | -388,138 | -319,813 | -199,425 |
| Interest Expense | 10,748 | 11,182 | 11,334 | 11,014 | 19,682 |
| Other Income | 24,299 | 14,499 | 23,362 | -328 | 2,224 |
| Pre-tax Income | -49,273 | -320,510 | -376,110 | -331,155 | -216,883 |
| Income Tax | 988 | 120 | 223 | 313 | 409 |
| Net Income Continuous | -50,261 | -320,630 | -376,333 | -331,468 | -217,292 |
| Net Income Discontinuous | 24,715 | -915 | 264,934 | 52,986 | 37,201 |
| Net Income | $-25,546 | $-321,545 | $-111,399 | $-278,482 | $-180,091 |
| EPS Basic Total Ops | -0.29 | -4.08 | -1.50 | -4.37 | -3.01 |
| EPS Basic Continuous Ops | -0.57 | -4.07 | -5.07 | -5.20 | -3.63 |
| EPS Basic Discontinuous Ops | 0.28 | -0.01 | 3.57 | 0.83 | 0.62 |
| EPS Diluted Total Ops | -0.29 | -4.08 | -1.50 | -4.37 | -3.01 |
| EPS Diluted Continuous Ops | -0.57 | -4.07 | -5.07 | -5.20 | -3.63 |
| EPS Diluted Discontinuous Ops | 0.28 | -0.01 | 3.57 | 0.83 | 0.62 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -4.07 | -5.07 | -4.37 | -3.01 |
| EBITDA(a) | $-4,877 | $-283,082 | $-355,346 | $-298,172 | $-173,429 |